Skip to main content
Have a personal or library account? Click to login
Adverse Effects Of Combined Mycotoxins / Štetni Učinci Kombiniranih Mikotoksina Cover

Adverse Effects Of Combined Mycotoxins / Štetni Učinci Kombiniranih Mikotoksina

Open Access
|Jan 2013

References

  1. 1. Pravilnik o najvećim dopuštenim količinama određenih kontaminanata u hrani [Regulations on maximum levels for certain contaminants in foodstuffs, in Croatian]. Narodne novine 154/2008.
  2. 2. Peraica M, Domijan A-M, Miletić-Medved M, Fuchs R. The involvement of mycotoxins in the development of endemic nephropathy. Wien Klin Wochenschr 2008;120:402-7.
  3. 3. Pepeljnjak S, Šegvić Klarić M. “Suspects” in etiology of endemic nephropathy: Aristolochic acidmycotoxins. Toxins 2010;2:1414-27.
  4. 4. Fazekas B, Kis M, Hajdu ET. Data on the contamination of maize with fumonisin B1 and other fusariotoxins in Hungary. Acta Vet Hung 1996;44:25-37.
  5. 5. Cirillo T, Ritieni A, Galvano F, Amodio Cocchieri R. Natural co-occurrence of deoxynivalenol and fumonisins B1 and B2 in Italina marketed foodstuffs. Food Addit Contam 2003;20:566-71.
  6. 6. Sokolović M, Šimpraga B. Survey of trichothecene mycotoxins in grains and animal feed in Croatia by thin layer chromatography. Food Contr 2006;17:733-40.
  7. 7. Jurjević Ž, Solfrizzo M, Cvjetković B, De Girolamo A, Visconti A. Occurrence of beauvericin in corn from Croatia. Food Technol Biotechnol 2002;40:91-4.
  8. 8. Vrabcheva T, Usleber E, Dietrich R, Martlbauer E. Cooccurrence of ochratoxin A and citrinin in cereals from bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem 2000;48:2483-8.
  9. 9. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 2007;51:1131-46.
  10. 10. Varga J, Kocsube S, Suri S, Szigeti GY, Szekeres A, Varga M, Toth B, Bartok T. Fumonisin contamination and fumonisin producing black Aspergilli in dried vine fruits of different origin. Int J Food Microbiol 2010;143:143-9.
  11. 11. Logrieco A, Ferracane R, Visconti A, Ritieni A. Natural occurrence of fumonisin B2 in red wine from Italy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010;27:1136-41.
  12. 12. Frisvad JC, Larsen TO, Thrane U, Meijer M, Varga J, Samson RA, Nielsen KF. Fumonisin and ochratoxin production in industrialstrains. Plos One 2011;6:1-6.
  13. 13. Garcia D, Ramos AJ, Sanchis V, Marin S. Predicting mycotoxins in foods: A review. Food Microbiol 2009;26:757-69.
  14. 14. Paterson RRM, Lima N. How will climate change affect mycotoxins in food? Food Res Int 2010;43:1902-14.
  15. 15. Šegvić Klarić M, Cvetnić Z, Pepeljnjak S, Kosalec I. Cooccurrence of aflatoxins, ochratoxin A, fumonisins, and zearalenone in cereals and feed, determined by competitive direct enzyme-linked immunosorbent assay and thin-layer chromatography. Arh Hig Rada Toksikol 2009;60:427-34.
  16. 16. Pepeljnjak S, Šegvić M. An overview of mycotoxins and toxigenic fungi in Croatia. In: Logrieco A, Visconti A, editors. An overview on toxigenic fungi and mycotoxins in Europe. Dordrecht: Kluwer Academic Publishers; 2004. p. 33-50.
  17. 17. Munkvold GP, Desjardins AE.in maize: can we reduce their occurrence? Plant Dis 1997;81:556-65.
  18. 18. Miraglia M, Marvin HJP, Kleter GA, Battilani P, Brera C, Coni E, Cubadda F, Croci L, De Santis B, Dekkers S, Filippi L, Hutjes RWA, Noordam MY, Pisante M, Piva G, Prandini A, Toti L, van den Born GJ, Vespermann A. Climate change and food safety: An emerging issue with special focus on Europe. Food Chem Toxicol 2009;47:1009-21.
  19. 19. Dojin R, Bullerman LB. Effect of cycling temperatures on the production of deoxynivalenol and zearalenone byNRRL 5883. J Food Prot 1999;62:1451-5.
  20. 20. Speijers GJA, Speijers MHM. Combined toxic effect of mycotoxins. Toxicol Lett 2004;153:91-8.
  21. 21. Riley RT. Mechanistic interactions of mycotoxins: theoretical consideration. In: Sinha, KK, Bhatanagar D, editors. Mycotoxins in agriculture and food safety. Basel, New York: Marcel Dekker Inc; 1998. p. 227-54.
  22. 22. Eisenbrand G, Pool-Zobel B, Baker V, Balls M, Blaauboer BJ, Boobis A, Carere A, Kevekordes S, Lhuguenot JC, Pieters R, Kleiner J. Methods oftoxicology. Food Chem Toxicol 2002;40:193-236.
  23. 23. Gutleb AC, Morrison E, Murk AJ. Cytotoxicity assay for mycotoxins produced bystrains: a review. Environ Toxicol Pharmacol 2002;11:309-20.
  24. 24. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 2005;21:1-26.
  25. 25. Wilkening S, Stahl F, Bader A. Comparison of primary human hepatocytes and hepatoma cell line hepg2 with regard to their biotransformation properties. Drug Metab Dispos 2003;31:1035-42.
  26. 26. Castell JV, Donato MT, Gomez-Lechon MJ. Metabolism and bioactivation of toxicants in the lung. Thecellular approach. Exp Toxicol Pathol 2005;57:189-204.
  27. 27. Tajima O, Schoen ED, Feron VJ, Groten JP. Statistically designed experiments in a tiered approach to screenmixtures ofmycotoxins for possible interactions. Food Chem Toxicol 2002;40:685-95.
  28. 28. Heussner AH, Dietrich DR, O’Brien E.investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells. Toxicol In Vitro 2006;20:332-41.
  29. 29. Tammer B, Lehmann I, Nieber K and Altenburger R. Combined effects of mycotoxin mixtures on human T cell function. Toxicol Lett 2007;170:124-33.
  30. 30. Ruiz M-J, Macakova P, Juan-Garcia A, Font G. Cytotoxic effects of mycotoxin combinations in mammalian kidney cells. Food Chem Toxicol 2011;49:2718-24.
  31. 31. Ruiz M-J, Franzova P, Juan-Garcia A, Font G. Toxicological interactions between the mycotoxins beauvericin, deoxynivalenol and T-2 toxin in CHO-K1 cells. Toxicon 2011;58:315-26.
  32. 32. Knecht A, Schwerdt G, Gekle M, Humpf H-U. Combinatory effects of citrinin and ochratoxin A in immortalized human proximal tubule cells. Mycotox Res 2005;21:176-81.
  33. 33. Šegvić Klarić M, Pepeljnjak S, Domijan A-M, Petrik J. Lipid peroxidation and glutathione levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B1, beauvericin and ochratoxin A. Basic Clin Pharmacol Toxicol 2007;100:157-64.
  34. 34. Šegvić Klarić M, Rumora L, Ljubanović D, Pepeljnjak S. Cytotoxicity and apoptosis induced by fumonisin B1, beauvericin and ochratoxin A in porcine kidney PK15 cells: effects of individual and combined treatment. Arch Toxicol 2008;82:247-55.
  35. 35. Šegvić Klarić M, Pepeljnjak S, Rozgaj R. Genotoxicity of fumonisin B1 beauvericin and ochratoxin A in porcine kidney PK15 cells: effects of individual and combined treatment. Croat Chem Acta 2008;81:139-46.
  36. 36. Šegvić Klarić M, Daraboš D, Rozgaj R, Kašuba V, Pepeljnjak S. Beauvericin and ochratoxin A genotoxicity evaluated using the alkaline comet assay: single and combined genotoxic action. Arch Toxicol 2010;84:641-50.
  37. 37. Šegvić Klarić M, Želježić D, Rumora L, Peraica M, Pepeljnjak S, Domijan A-M. A potential role of calcium in apoptosis and aberrant chromatin forms in porcine kidney PK15 cells induced by individual and combined ochratoxin A and citrinin. Arch Toxicol 2012;86:97-107.
  38. 38. Huff WE, Doerr JA. Synergism between aflatoxin and ochratoxin A in broiler chickens. Poult Sci 1981;60:550-5.
  39. 39. McKean C, Tang L, Tang M, Billam M, Wang Z, Theodorakis CW, Kendall RJ, Wang J-S. Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells. Food Chem Toxicol 2006;44:868-76.
  40. 40. Thuvander A, Wikman C, Gadhasson I.exposure of human lymphocytes to trichothecenes: Individual variation on sensitivity and effects of combined exposure on lymphocyte function. Food Chem Toxicol 1999;37:639-48.
  41. 41. Yike I, Allan T, Sorenson WG, Deraborn DG. Highly sensitive protein translation assay for trichothecene toxicity in airborne particulates: comparison with cytotoxicity assays. Appl Environ Microbiol 1999;65:88-94.
  42. 42. Morrison E, Rundberget T, Kosiak B, Aastveit Ah, Bernhoft A. Cytotoxicity of trichothecenes and fusarochromanone produced by Fusarium equiseti strains isolated from Norwegian cereals. Mycopathologia 2002;153:49-56.
  43. 43. Uhlig S, Gutleb AC, Thrane U, Flaoyen A. Identification of cytotoxic principles fromusing bioassay-guided fractionation. Toxicon 2005;46:150-9.
  44. 44. Luongo D, Severino L, Bergamo P, De Luna R, Lucisano A, Rossi M. Interactive effects of fumonisin B1 and a-zearalenol on proliferation and cytokine expression in Jurkat T cells. Toxicol In Vitro 2006;20:1403-10.
  45. 45. Dombrink-Kurtzman MA. Fumonisin and beauvericin induce apoptosis in turkey peripheral blood lymphocytes. Mycopathologia 2003;156:357-64.
  46. 46. Morris CM, Li YC, Ledoux DR, Bermudez AJ, Rottinghaus GE. The individual and combined effects of feeding moniliformin, supplied byculture material, and deoxynivalenol in young turkey poults. Poult Sci 1999;78:1110-5.
  47. 47. Kubena LF, Edrington TS, Harvey RB, Phillips TD, Sarr AB, Rottinghaus GE. Individual and combined effects of fumonisin B1 present inculture material and diacetoxyscirpenol or ochratoxin A in turkey poults. Poult Sci 1997;76:256-64.
  48. 48. Muller G, Kielstein P, Rosner H, Berndt A, Heller M, Kohler H. Studies on the influence of combined administration of ochratoxin A, fumonisin B1, deoxynivalenol and T-2 toxin on immune and defence reactions in weaner pigs. Mycoses 1999;42:485-93.
  49. 49. Bracarense A-PFL, Lucioli J, Grenier B, Pacheco GD, Moll W-D, Schatzmayr G, Oswald IP. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br J Nutr 2012;107:1776-86.
  50. 50. Pfohl-Leszkowicz A, Manderville RA. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 2007;51:61-99.
  51. 51. Peraica M, Flajs D, Domijan A-M, Ivić D, Cvjetković B. Ochratoxin A contamination of food from Croatia.2010;:2098-105.
  52. 52. Heussner AH, O`Brien E, Haehnlein J, Biester MA, Dietrich DR. Comparison of interactive cytotoxic effects of selected mycotoxins on renal cells. Toxicol Sci 2004;78(Suppl 1):89.
  53. 53. Bouslimi A, Bouaziz C, Ayed-Boussema I, Hassen W, Bacha H. Individual and combined effects of ochratoxin A and citrinin on viability and DNA fragmentation in cultured Vero cells and chromosome abberations in mice bone marrow cells. Toxicology 2008;251:1-7.
  54. 54. Manderville RA, Pfohl-Leszkowicz A. Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesisMycotoxin J 2008;1:357-67
  55. 55. Pfohl-Leszkowicz A, Molinie A, Tozlovanu M, Manderville RA. Combined toxic effects of ochratoxin A and citrinin,and. In: Siantar DP, Trucksess MW, Scott PM, Herman EM, editors. Food contaminants, mycotoxins and food allergen. Washington (D)C; American Chemical Society; 2008. p. 56-80.
  56. 56. Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville RA. Genotoxicity of the hydroquinone metabolite of ochratoxin A: Structure-activity relationships for covalent DNA adduction. Chem Res Toxicol 2006;19:1241-7.
  57. 57. Mantle P, Faucet-Marquis V, Manderville R, Sciqualli B, Pfohl-Leszkowicz A. Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 2010;23:89-98.
  58. 58. Creppy EE, Chirappa P, Baudrimont I, Borracci P, Moukha S, Carratu MR. Synergistic effects of fumonisn B1 and ochratoxin A: arecytotoxicity data predictive ofacute toxicity? Toxicology 2004;201:115-23.
  59. 59. Domijan A-M, Želježić D, Kopjar N, Peraica M. Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B1-treated rats. Toxicology 2006;222:53-9.
  60. 60. Hadjeba-Medjdoub K, Faucet-Marquis V, Tozlovanu M, Peraica M, Manderville RA, Pfohl-Leszkowicz A. Synergistic effect of three nephrotoxic and carcinogenic mycotoxins (citrinin, fumonisin, ochratoxin A) on human kidney cells viability and genotoxicity. In: Antolović R, Miličević T, editors. Symposium “Power of fungi and mycotoxins in health and disease”; 19-22 Oct 2011; Primošten, Croatia 2011. Book of abstracts p. 57.
  61. 61. Stoev SD, Gundasheva D, Zarkov I, Mircheva T, Zapryanova D, Denev S, Mitev Y, Daskalov H, Dutton M, Mwanza M, Schneider Y-J. Experimental mycotoxic nephropathy in pigs provoked by a mouldy diet containing ochratoxin A and fumonisin B1. Exp Toxicol Pathol 2012;64:733-41.
  62. 62. Stoev SD, Dutton M, Njobeh P, Mosonik J, Steenkamp P. Mycotoxic nephropathy in Bulgarian pigs and chickens: complex aetiology and similarity to Balkan Endemic Nephropathy. Food Addit Contam A Chem Anal Control Expo Risk Assess. 2010;27:72-88.
  63. 63. Stoev SD, Denev S, Dutton M, Njobeh P, Mosonik J, Steenkamp P, Petkov I. Complex etiology and pathology of mycotoxic nephropathy in South African pigs. Mycotox Res 2010;26:31-46.
  64. 64. Stoev SD, Vitanov S, Anguelov G, Petkova-Bocharova T, Creppy EE. Experimental mycotoxic nephropathy in pigs provoked by a mouldy diet containing ochratoxin A and penicillic acid. Vet Res Commun 2001;25:205-23.
  65. 65. Stoev SD, Stefanov M, Denev S, Radić B, Domijan A-M, Peraica M. Experimental mycotoxicosis in chickens induced by ochratoxin A and penicillic acid and intervention by natural plant extracts. Vet Res Commun 2004;28:727-46.
  66. 66. Riley RT, Norred WP. Mechanisms of mycotoxicity. In: Howard DH, Miller JD, editors. The mycota. Vol VI. Berlin: Springer; 1996: p. 194-5.
  67. 67. International Agency for Research on Cancer (IARC). Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 82. Lyon: IARC Press; 2002.
  68. 68. Ueno Y, Iijima K, Wang S-D, Suguira Y, Sekijima M, Tanaka T, Chen C, Yu S-Z. Fumonisins as a possible contributing risk factor for primary liver cancer: a 3 year study of corn harvested in Haimen, China by HPLC and ELISA. Food Chem Toxicol 1997;35:1143-50.
  69. 69. Li FQ, Yoshizawa T, Kawamura O, Luo XY, Li YW. aflatoxins and fumonisins in corn from the high-incidence area for human hepatocellular carcinoma in Guangxi, China. J Agric Food Chem 2001;49:4122-26.
  70. 70. Harvey RB, Edrington TS, Kubena LF. Influence of aflatoxin and fumonisin B1 containing culture material on growing barrows. Am J Vet Res 1995;56:1668-72.
  71. 71. Kubena LF, Edrington TS, Kampsholtzapple C, Harvey RB, Elissalde MH, Rottinghaus GE. Effects of feeding fumonisin B1 present in Fusarium moniliforme culture material and aflatoxin singly and in combination to Turkey poults. Poultry Sci 1995;74:1295-303.
  72. 72. Pozzi CR, Correa B, Xavier JG, Direito GM, Orsi RB, Matarazzo SV. Effects of prolonged oral administration of fumonisin B1 and aflatoxin B1 in rats. Mycopathologia 2001;151:21-7.
  73. 73. Gelderblom WCA, Marasas WFO, Lebepe-Mazur S, Swanevelder S, Vessey CJ, Hall P de la M. Interaction of fumonisin B1 and aflatoxin B1 in a short term carcinogenesis model in rat liver. Toxicology 2002;171:161-73.
  74. 74. Carlson DB, Williams DE, Spitsbergen JM, Ross PF, Bacon CW, Meredith FI, Riley RT. Fumonisin B1 promotes aflatoxin B1 and-methyl-Nitro-nitrosoguanidine initiated liver tumors in rainbow trout. Toxicol Appl Pharmacol 2001;172:29-36.
  75. 75. Gelderblom WCA, Abel S, Smuts CM, Marnewick J, Marasas WFO, Lemmer EW, Ramljak D. Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion. Environ Health Perspect 2001;109(Suppl 2):291-300.
  76. 76. Theumer MG, Lopez AG, Aoki MP, Canepa MC, Rubinstein HR.. Subchronic mycotoxicoses in rats. Histopathological changes and modulation of the sphinganine to sphingosine (Sa/So) ratio imbalance induced by Fusarium verticillioides culture material, due to the coexistence of aflatoxin B1 in the diet. Food Chem Toxicol 2008;46:967-77.
  77. 77. Theumer MG, Lopez AG, Masih DT, Chulze SN, Rubinstein HR. Immunobiological effects of AFB1 and AFB1-FB1 mixture in experimental subchronic mycotoxicoses in rats. Toxicology 2003;186:159-70.
  78. 78. Theumer MG, Canepa MC, Lopez AG, Mary VS, Dambolena JS, Rubinstein HR. Subchronic mycotoxicoses in Wistar rats: Assessment of theandgenotoxicity induced by fumonisins and aflatoxin B1, and oxidative stress biomarkers status. Toxicology 2010;268:104-10.
  79. 79. McKean C, Tang L, Billam M, Tang M, Theodorakis CW, Kendall RJ, Wang JS. Comparative acute and combinative toxicity of aflatoxin B1 and T-2 toxin in animals and immortalized human cell lines. J Appl Toxicol 2006;26:139-47.
  80. 80. Golli-Bennour EE, Kouidhi B, Bouslimi A, Abid-Essefi S, Hassen W, Bacha H. Cytotoxicity and genotoxicity induced by aflatoxin B1, ochratoxin A, and their combination in cultured Vero cells. J Biochem Mol Toxicol 2010;24:42-50.
  81. 81. Bottalico A, Logrieco A, Ritieni A, Moretti A, Randazzo G, Corda P. Beauvericin and fumonisin B1 in preharvest Fusarium moniliforme maize ear rot in Sardinia. Food Addit Contam 1995;12:599-607.
  82. 82. Domijan A-M, Peraica M, Jurjević Ž, Ivić D, Cvjetković B. Fumonisin B1, fumonisin B2, zearalenone and ochratoxin A contamination of maize in Croatia. Food Addit Contam 2005;22:677-80.
  83. 83. Fazekas B, Tar A, Kovacs M. aflatoxin and ochratoxin A content of spices in Hungary. Food Addit Contam 2005;22:856-63.
  84. 84. Raiola A, Meca G, Manes J, Ritieni A. Bioaccessibility of deoxynivalenol and its natural co-occurrence with ochratoxin A and aflatoxin B1 in Italian commercial pasta. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2012;50:280-7.
  85. 85. Šegvić Klarić M, Pepeljnjak S. Bovericin: kemizam, biološki aspekti i raširenost. [Beauvericin: chemical and biological aspects and occurrence, in Croatian]. Arh Hig Rada Toksikol 2005;56:343-50.
  86. 86. Chagas GM, Campello AP, Kluppel ML. Mechanism of citrinin-induced dysfunction of mitochondria. I. Effects on respiration enzyme activities and membrane potential of renal cortical mitochondria. J Appl Toxicol 1992;12:123-9.
  87. 87. Da Lozo EJ, Oliveira MB, Carnieri EG. Citrinin-induced mitochondrial permeability transition. J Biochem Mol Toxicol 1998;12:291-7.
  88. 88. International Agency for Research on Cancer (IARC). Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC; 1993.
  89. 89. Yazar S, Omurtag GZ. Fumonisins, trichothecenes and zearalenone in cereals. Int J Mol Sci 2008;9:2062-90.
  90. 90. Pestka JJ, Zhou H, Moon Y, Chung YJ. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett 2004;153:61-73.
  91. 91. International Agency for Research on Cancer (IARC). Toxins derivied from,and. In: IARC Monographs on the evaluation of carcinogenic risks to humans, some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Vol. 56. Lyon: IARC Press; 1993. p. 397-444.
  92. 92. Schuhmacher-Wolz U, Heine K, Schneider K. Report on toxicity data on trichothecene mycotoxins HT-2 and T-2 toxins. CT/EFSA/CONTAM/2010/03 [displayed 31 October 2012]. Available at http://www.efsa.europa.eu/en/scdocs/doc/65e.pdf
  93. 93. Riley RT, Wang E, Schroeder JJ, Smith ER, Plattner RD, Abbas H, Yoo HS, Merill AH Jr. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat Toxins 1996;4:3-15.
  94. 94. International Agency for Research on Cancer (IARC). Ochratoxin A. In: IARC Monographs on the evaluation of carcinogenic risks to humans, some naturally occurring substances:food items and constituents, heterocyclic aromatic amines and mycotoxins. Vol. 56. Lyon: IARC Press; 1993. p. 489-521.
DOI: https://doi.org/10.2478/10004-1254-63-2012-2299 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 519 - 530
Published on: Jan 16, 2013
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2013 Maja Šegvić Klarić, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.